3 recruiting, 1 not yet recruiting. 4 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Recruiting 3, Not yet recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Type 1 Diabetes (T1D): new trials by email Literature Review of Type 1 Diabetes (T1D) trials Research Report on Type 1 Diabetes (T1D)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Research Study Investigating the Effect of NNC0497-0040 in Healthy Participants, Participants With Overweight or Obesity, and Participants With Type 1 Diabetes With Overweight or Obesity NNC0497-0040, Placebo - Type 1 Diabetes (T1D), Overweight | Phase 1 | Recruiting | Novo Nordisk A/S | 146 | 2026-05-07 | 2026-06-04 |
| Study of IMC-S118AI in Type 1 Diabetes IMC-S118AI - Type 1 Diabetes, Type 1 Diabetes (T1D) | Phase 1 | Not yet recruiting | Immunocore Ltd | 154 | 2026-04-01 | 2026-03-25 |
| A Study of GNTI-122 in Adults Recently Diagnosed With T1D GNTI-122 - Type 1 Diabetes (T1D), Type 1 Diabetes Mellitus | Phase 1 | Recruiting | GentiBio, Inc | 16 | 2025-09-03 | 2026-10-20 |
| A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus OPF-310 - Diabetes Mellitus, Type 1, Hypoglycemia | Phase 1 / Phase 2 | Recruiting | Otsuka Pharmaceutical Factory, Inc. | 13 | 2025-06-10 | 2026-08-21 |
Diabetes Mellitus, Type 1 (4) · Diabetes Mellitus (2) · Autoimmune Diseases (1) · Glucose Metabolism Disorders (1) · Hypoglycemia (1) · Immune System Diseases (1) · Metabolic Diseases (1) · Obesity (1) · Overweight (1)
Endocrine System Diseases (4) · Nutritional and Metabolic Diseases (4) · Autoimmune Diseases (3) · Glucose Metabolism Disorders (3) · Immune System Diseases (3) · Metabolic Diseases (3) · Diabetes Mellitus (2) · Body Weight (1) · Nutrition Disorders (1) · Overnutrition (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
GentiBio, Inc (1) · Immunocore Ltd (1) · Novo Nordisk A/S (1) · Otsuka Pharmaceutical Factory, Inc. (1)
United States (2) · Germany (1)
Mark Bach, MD (1)
2025 (1)